Zepto Life Technology
PrivateLast Round
Grant
Jan 17, 2025
Total Funding Raised
$11.51M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Zepto Life Technology operates in Healthcare & Life Sciences and is based in Saint Paul, Minnesota. Its latest recorded funding round was a Grant round in January 2025.
Zepto Life Technology is a biotechnology company that develops molecular diagnostics platforms and provides clinical laboratory testing services for infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zepto Life Technology Comparables
Compare Zepto Life Technology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Karius | 75% | |
| bioMérieux | 67% | |
| Immuno-Mycologics, Inc. | 62% |
For institutional investors. Book with your work email.
Zepto Life Technology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 17, 2025 | ||||
| Seed | Oct 1, 2022 | ||||
| Accelerator | Mar 1, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Zepto Life Technology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Launch Minnesota | Grant |
| HM Venture Partners | Seed |
| University of Minnesota | Grant, Accelerator |
| Medical Alley Association | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 26, 2026
Open roles increased to 6, representing 23% of headcount.
- Oct 6, 2026
Open roles increased to 5, 19% of headcount.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingAug 11, 2026
Zepto Life Technology, LLC receives an initial $1.9M NIAID contract award to advance its Zepto MDx infectious-disease liquid biopsy platform, with up to $8.9M available if all contract options are exercised.
For institutional investors. Book with your work email.
Zepto Life Technology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Zepto Life Technology's valuation, stock price, and market status.
Is Zepto Life Technology a public or private company?
Zepto Life Technology is a private company.
What is the current stock price of Zepto Life Technology?
Zepto Life Technology is a private company, so its shares have no public market price. Caplight tracks Zepto Life Technology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Zepto Life Technology worth (valuation)?
Valuation information for Zepto Life Technology is not publicly available.
Can I buy Zepto Life Technology stock?
Zepto Life Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Zepto Life Technology's last funding round?
Zepto Life Technology's most recent funding round was Grant on January 17, 2025.
Who are the main investors in Zepto Life Technology?
Key investors in Zepto Life Technology include HM Venture Partners.
Will Zepto Life Technology IPO soon?
No public IPO plans have been announced for Zepto Life Technology.
How can I track Zepto Life Technology secondary market activity?
Caplight tracks bids, offers, and trades in Zepto Life Technology's shares on secondary markets.